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Abstract
Gene network information has been used to improve gene selection in microarray-based studies by selecting marker genes
based both on their expression and the coordinate expression of genes within their gene network under a given condition.
Here we propose a new network-embedded gene selection model. In this model, we first address the limitations of
microarray data. Microarray data, although widely used for gene selection, measures only mRNA abundance, which does not
always reflect the ultimate gene phenotype, since it does not account for post-transcriptional effects. To overcome this
important (critical in certain cases) but ignored-in-almost-all-existing-studies limitation, we design a new strategy to
integrate together microarray data with the information of microRNA, the major post-transcriptional regulatory factor. We
also handle the challenges led by gene collaboration mechanism. To incorporate the biological facts that genes without
direct interactions may work closely due to signal transduction and that two genes may be functionally connected through
multi paths, we adopt the concept of diffusion distance. This concept permits us to simulate biological signal propagation
and therefore to estimate the collaboration probability for all gene pairs, directly or indirectly-connected, according to multi
paths connecting them. We demonstrate, using type 2 diabetes (DM2) as an example, that the proposed strategies can
enhance the identification of functional gene partners, which is the key issue in a network-embedded gene selection model.
More importantly, we show that our gene selection model outperforms related ones. Genes selected by our model 1) have
improved classification capability; 2) agree with biological evidence of DM2-association; and 3) are involved in many well-
known DM2-associated pathways.
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Introduction
A fundamental goal of modern biology is to understand
complex biological phenomena at the molecular level. In most
cases, the first step towards achieving this goal is to isolate genes
that are important to a particular biological process. Various
statistical concepts and machine learning models have been used
to identify genes in microarray data that reveal differential
expression patterns according to a selected phenotype status,
including t-, F- and Wilcoxon statistics and signal-noise-ratio [1],
mutual information [2], support vector machine [3], Bayesian
network [4], and random forest [5] approaches. Strategies have
also been proposed to address different issues, such as noisy data
and small sample size [6,7,8]. More recently, gene interaction
information has been introduced into the gene selection (GS)
process to account for the known ability of genes to interact or
react within pathways or common modules. These approaches
first identify differentially-expressed genes within microarray data,
and then evaluate the performance of pre-defined functional gene
categories (or networks) to identify the genes that associate with the
phenotype of interest (see [9] for a comprehensive review of these
approaches). Gene functional category or network information can
improve the sensitivity of GS, detecting useful genes that only
present subtle expression changes among different assayed
phenotypes. For example, in a pioneering study, gene set
enrichment analysis (GSEA) was used to identify a set of oxidative
phosphorylation-related genes that modestly but coordinately
decrease in skeletal muscle of diabetic human subjects. Research-
ers have since further modified this type of analysis by
incorporating the topology of gene networks. Rahnenfu ¨hrer et
al. [10] have emphasized gene pairs with little network distance to
score the cooperativeness of a gene network. Rapaport et al. [11],
after assuming that genes and their network neighbors should
show similar expression levels, have used a spectral-graph-based
method to reduce microarray data noise in order to enhance
classification accuracy. More recently, Wei and Li [12] designed a
Markov random field model to evaluate genes based on both their
own expression and the expression of their directly-connected
neighbors. The results from all these studies demonstrate that
analyzing the topology of gene networks can improve GS and
classification.
Microarray values represent the levels of gene transcripts (i.e.,
mRNAs), and are routinely used as direct surrogates for gene
expression in most GS methods developed to date, including all
the methods cited above. This requires the implicit assumption
that gene expression directly mirrors gene transcript levels. This
assumption appears to be acceptable since it is consistent with
biological observation in most cases [13]. Direct overlay of mRNA
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produce promising results. However, improvement is still needed,
since post-transcriptional processes have been widely reported to
impact gene expression levels, sometimes to great effect.
MicroRNA expression has recently been shown to be a very
important means of posttranscriptional regulation of gene
expression. MicroRNAs regulate metazoan gene expression by
complementarily binding to frequently-imperfect recognition
sequences that are predominantly located within the 39 untrans-
lated regions (UTR) of a target mRNA, with few exceptions
[14,15]. MicroRNAs can regulate the expression of their target
genes at multiple levels, blocking mRNA translation and/or
inducing mRNA degradation [16], and have been suggested to
play roles in a broad range of biological processes, such as
developmental timing, cell growth and differentiation, apoptosis
and cell proliferation. Furthermore, accumulating evidence implies
that microRNAs are associated with bio-molecular characteristics
of various human complex diseases, such as cancer [17,18] and
diabetes [19,20]. With these observations, and supported by the
advances already made in the study of microRNA, it is necessary
and possible for a GS model to address potential regulatory
microRNA effects.
We herein propose a microRNA-integrated network-embedded
gene selection (MiNeGS) model to investigate the ability of
microRNA information to enhance GS. Our model has two major
contributions. First, microarray data and microRNA binding
information are integrated prior to evaluation of gene correlation,
since mRNA expression level and microRNA-mediated post-
transcriptional regulation are known to be key factors influencing
gene expression. We propose that two genes are closely correlated
when their mRNA levels vary coordinately in the face of similar
potential microRNA regulation on them. Gene transcript levels
are directly derived from microarray data, while microRNA
regulatory effects are modeled using mRNA sequence information,
with the assumption that mRNA with similar putative microRNA
binding sites are likely to experience similar posttranscriptional
regulation. Second, we introduce the concept of diffusion distance
to detect the nearest functional partners (NFPs) of a gene. Genes
generally interact in highly complicated patterns. Genes, either
having direct or indirect network connections to each other, may
function closely [21], through signal transduction. Also the signal
transduction from one gene to another can be done through
multiple paths, instead of a single one. We therefore utilize the
concepts of diffuse distance and diffuse maps [22] in order to
detect both directly- and indirectly-interacting NFPs as well as to
capture potential multi-path connections between genes.
Results and Discussion
A. Overview of the proposed MiNeGS model
Our microRNA-integrated network-embedded gene selection
model (MiNeGS) includes three components (A, B and C), as
depicted in Fig. 1 and further described in Materials and Methods.
Briefly, in Part A, the expression similarity between two genes is
calculated based on two factors: their steady-state mRNA
expression levels, recorded by microarray data, and their potential
from microRNA-mediated posttranscriptional regulation, as
indicated by their microRNA binding sites. In Part B, gene
correlations estimated in Part A are used to weight the edges of our
gene network. Based on this weighted gene network, the functional
distance of any two genes are evaluated using the concept of
diffusion distance, and the genes with the k smallest functional
distance to gene g are selected as its nearest functional partners
(NFPs). Small k values prevent the exploitation of network
information, restricting the contributions of our network-based
GS strategy, while large k values may link genes with NFPs that do
not share the same functions or fall within the same pathways. In
this study, we set k with a modest value, k=3, to avoid over- and
under-identification of NFPs. Finally, in Part C, gene-phenotype
associations are estimated for all genes by averaging the
expression-based correlations of genes and their NFPs. Compu-
tational analyses performed using these three components allow
genes with high phenotype correlations to be selected from the
dataset. Our major contributions lie in the development of a
method to integrate gene expression and microRNA binding
information (Part A) and a diffusion-distance-based strategy for
network-embedded NFP identification (Part B).
In order to evaluate the utility of the MiNeGS approach, we
have compared it with a classical GS model in which all genes are
treated individually. We have also evaluated the relative individual
contributions of the two new aspects of the MiNeGS model by
comparing MiNeGS with a microRNA-integrated GS model
(MiGS; Parts A and C) and a network-embedded GS model
(NeGS; Parts B and C). In the MiGS model, only the microRNA-
integrated strategy is used to modify the classic GS. For a given a
gene g, MiGS simply selects the highest-correlated k genes (k=3
for consistency with MiNeGS) from g’s first-order neighbors (i.e.,
those directly linked to g in a given network). In the NeGS model,
gene-gene correlations are estimated solely using microarray
mRNA expression data. Comparisons between MiGS and
MiNeGS reveal the benefits of a diffusion-distance-based NFP
identification strategy, while comparisons between NeGS and
MiNeGS indicate the contributions of integrating microRNA
information with microarray data.
We used these models to analyze a diabetes microarray dataset.
This dataset, published by Mootha et al [23], records the
expression profiles of 22,000 genes in skeletal muscle biopsies of
43 age-matched men – 17 with normal glucose tolerance (NGT), 8
with impaired glucose tolerance (IGT) and 18 with type 2 diabetes
mellitus (DM2). We used the 17 NGT and 18 DM2 samples from
this dataset in order to focus our analysis on the detection of DM2-
associated genes.
B. MiNeGS identifies functionally coordinated genes
We first evaluated the NFP-identification performance of
MiNeGS. Since most genes act within a single functional pathway,
rather than across different pathways (i.e., do not play a role in
crosstalk between pathways), we identified the 3 closest functional
gene partners for each gene as its NFPs. It thus could be expected
that genes and their NFPs are located within the same functional
pathway, sharing common GO annotations or pathway assign-
ments. With this idea, we estimated the functional coordination
status of each gene and its NFPs. We considered a given gene g
and its three NFPs (assuming that all of them have been annotated
with a GO term or pathway assignment) to be functionally
coordinated when at least 3 of them could be placed into common
GO categories or pathways. In order to avoid erroneously
estimates, we discarded large GO annotation categories and
pathways (.200 genes) during our coordination analysis.
The coordination rates of MiGS (43%) and MiNeGS (42%) are
better, albeit not remarkably so, than that of NeGS (40%). These
comparisons suggest that microRNA:gene target information can
improve NFP identification. NFP coordination rates of MiGS and
MiNeGS are similar, but MiGS only considers first-order network
neighbors and is thus unable to assign NFPs to genes that have
fewer than 3 first-order network connections in our study, while
MiNeGS, which is not limited to first-order connections, can
assign NFPs to all given genes. Due to the scale-free nature of gene
MiRNA Network Gene Selection
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gene interactions, a large number of genes have few detected
connections. In our study, 52% of the data set (1029 genes) had
fewer than 3 first-order neighbors and could thus not be analyzed
by MiGS. Under such situations, MiNeGS exploits more network
information than MiGS, and MiNeGS outperforms MiGS in
terms of GS, as indicated later.
Built-in factors of datasets may influence coordination rates. We
therefore performed two additional analyses in order to determine the
potential contribution of built-in dataset factors. First, to analyze the
possible contributions of GO annotations and pathway assignments,
we generated NFPs by randomly selecting 3 genes as the NFPs for a
given gene and determined the coordination rate on the entire gene
set. After repeating this process 100 times, the coordination rate
distribution of the randomized NFPs was estimated. Second, to
evaluate the influence of network topology, we generated network-
based random NFPs for each gene by randomly selecting 3 genes
from its first order network neighbors. After repeating this process
100 times we established the coordination rate distribution of the
network-based random NFPs. Coordination rates derived from these
two randomization processes, depicted as violin plots in Fig. 2, are
significantly lower than that of MiNeGS (one sample t-test p-values
were estimated as 4610
2136 when compared with the randomized
NFPs and as 3610
271 when compared with network-based
randomized NFPs).Withthesealmost-zerop-values, we can conclude
that built-in dataset factors are not responsible for the coordination
rate achieved by MiNeGS and, thus, that MiNeGS is able to
effectively identify functional NFPs.
C. MiNeGS increases classification accuracy
The utility of a GS model ultimately rests in its classification
performance, the ability to identify genes that can distinct the
samples with different phenotypes. When the genes selected by a
GS model enable classifiers to achieve high classification accuracy,
the tested GS model can be regarded as good. We therefore
examined the performance of MiNeGS by the corresponding
classification results. We employed two typical classifiers, i.e.,
neural networks and support vector machine, for our evaluation.
In order to avoid the ‘‘information leakage’’ and the randomness
caused by partitioning analysis samples into training and testing
groups, we adopted a cross validation scheme, and independently
ran this scheme 20 times. In order to make comprehensive
comparisons, we used each model to produce a series of gene
subsets, containing from 1 to 30 selected genes, and measured
classification performance by the area under the receiver operating
characteristic curve (AUC), as detailed in Materials and Methods.
Results of these analyses are shown in Fig. 3. Large AUCs indicate
good classification performance, and thus correspond to a
promising GS model. MiNeGS AUCs were generally better than
those achieved by the classic GS model when using either neural
Figure 1. Outline of the proposed method.
doi:10.1371/journal.pone.0013748.g001
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the classification improvements, we conclude that the effective use
of microRNA target and gene network information can enhance
the performance of GS. Also, in our example, SVM basically
outperforms NN in that, using the classic GS model, AUCs
reached by NNs is less than 0.7 at almost all cases, while SVMs
can arrive AUC.0.75 in the most cases when the number of
selected genes .7. As such the improvements measured by SVM
AUC are thus not as remarkable as by NN AUC.
D. MiNeGS detects more DM2-associated genes than
other GS methods
DM2 has been actively studied for decades, resulting in the
accumulation of a large body of biological and clinical results that
can be explored to evaluate the performance of our GS models.
We assemble a list of DM2-associated genes from multiple sources,
a recently published article [24] and three public databases. The
public databases are T2D-Db (available at http://t2ddb.ibab.ac.
in/home.shtml), HuGe Navigator [25] and the curated database
of the Ingenuity Pathway Analysis software. Based on information
from these sources, we identified 119 DM2-associated genes from
our gene set, and used them as ‘‘hallmark’’ genes to evaluate the
performance of our GS model. We considered the inclusion of
these hallmark genes in a GS result as an indicator of appropriate
GS, and that increases in the number of these hallmark genes
indicated improved GS performance.
As shown in Fig. 4, all MiGS, NeGS and MiNeGS identified
more DM2 hallmark genes than classical GS when they were used
to select relatively large gene sets. MiNeGS identify the most
hallmark genes, followed by NeGS and MiGS. This suggests that
inclusion of microRNA and network information can improve the
performance of GS. MiGS and NeGS address different informa-
tion and modify the GS model from different perspectives. NeGS
performs modestly better than MiGS, possibly due to 1) modest or
variable miRNA regulatory effects [26] and/or 2) potential noise
contamination of the currently available microRNA binding
information [16]. However, despite these potential problems,
microRNA information retains selective power since more
hallmark genes can be detected out when MiGS is compared
with the classic GS, and MiNeGS is compared with NeGS.
Table 1 lists the first 20 genes selected by MiNeGS. Of these
genes, some play functions in energy metabolism and inflamma-
tion, the processes known to have close DM2 associations. Also,
among these 20 genes, 6 are hallmark genes. Several of the
remaining genes, moreover, are either associated with DM2-
related conditions, such as obesity, or are supported by recently
published evidence. For example, F13A1 has been linked to two
DM2 related diseases, obesity and inflammation, according to the
HuGe knowledge base. The protein encoded by DYNLL1 is part
of the cytoplasmic dynein motor, which can regulate glucose-
induced insulin secretion [27]. Several of the remaining genes have
not been well studied, having few or no references in the HuGe or
NCBI GeneRIF databases, so that it is difficult to evaluate their
potential DM2 association.
E. Genes selected by MiNeGS are involved in DM2 related
pathways/processes
Finally, we examined the biological significance of gene
selection results through comparing selected genes with functional
Figure 2. MiNeGS can identify functional coordinated NFPs
with high significance.
doi:10.1371/journal.pone.0013748.g002
Figure 3. Comparisons of the classification performance of classic GS and MiNeGS approaches, using ROC AUC to measure
classification performance.
doi:10.1371/journal.pone.0013748.g003
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biological evidence, consist of genes that exert the same or related
functional roles, participate in the same signaling or metabolic
pathways, or are located within the same cytogenetic band. We
organized functional gene subsets based on gene annotation and
pathway information. We downloaded gene annotations from
Gene ontology database (http://www.geneontology.org/), and
pathway information from two databases, the molecular signature
database (MSigDB) and the pathway interaction database (PID).
MsigDB (available at http://www.broad.mit.edu/gsea/msigdb/
index.jsp), compiles information from multiple different sites
(BioCarta, KEGG, GenMAPP, etc.), while the PID database
(http://pid.nci.nih.gov/) is curated by editors of the Nature
Publishing Group and reviewed by experts in the field. The above
databases result to 4152 distinct functional gene subsets, 3404 of
which are derived from GO categories and the rest from the
pathway databases.
We used the DM2 hallmark genes (as introduced in the last
section) to identify DM2-associated functional gene subsets in a
statistic way. Briefly, for each functional gene subset, its
enrichment p-value was estimated under a hyper-geometric
statistics framework. After that, all enrichment p-values were
corrected according to the multiple hypotheses testing scheme
proposed by Benjamini et al [28] to control the false-positive rate
of this analysis. Small (,10 genes) and large (.200 genes)
functional gene subsets were excluded in order to achieve reliable
enrichment estimations. Based on these initial parameters and
using a corrected p-value of p,0.1 as the threshold for statistical
significance, we detected 60 DM2-associated functional gene
subsets, representing 34 GO categories and 26 pathways (5 from
PID and 21 from MsigDB). The majority of these gene subsets
represent processes with well-established DM2 associations (such
as, glucose metabolism, peroxisome proliferator-activated receptor
(PPAR) signaling, insulin signaling, lipid metabolism, etc.), while a
few are fundamental or essential biological processes (for instance,
MAPK signaling, cell adherance, and molecular transport, etc.).
We compared each GS result against all DM2-associated genes
in the way mentioned in the last paragraph, i.e., using
hypergeometric distribution-based significance enrichment evalu-
ation with Benjamini false-discovery rate correction, to detect
functional gene subsets enriched by the selection. The relative
selective performance of four different GS models is presented in
Fig. 5, with more selected DM2-associated subsets indicating
better selective performance. All four methods produce similar
results when used to select 100 genes. Note, however, that with
increasing numbers of selected genes all three of the modified GS
models (MiGS, NeGS and MiNeGS) identify more DM2-
associated gene sets than the classical GS model, whose
identification rate does not change. MiNeGS identified the most
DM2-associated gene subsets when 200 or 300 genes were selected
Figure 4. Evaluations based on the DM2 hallmark genes.
doi:10.1371/journal.pone.0013748.g004
Table 1. Top 20 MiNeGS selected genes.
Gene Name Rank DM2 hallmark GeneRIF HuGe
Energy metabolism
PFKFB1 2 Yes 1 0
FH 3 Yes 28 8
PDK4 6 Yes 14 1
NDUFA10 7 Yes 0 2
Cytoskeleton and cell motility
TCAP 9 No 11 0
DYSF 10 No 35 0
FLNC 11 No 11 0
ACTN2 12 No 5 1
MYH7 13 No 32 11
PLS3 14 No 6 0
GSN 15 No 47 0
Inflammation
EGFR 16 Yes 1013 65
AGE-R1 17 Yes 0 0
Others
SLA 1 No 1 0
ADSL 4 No 8 0
TRIM38 5 No 0 0
EIF3S9 8 No 1 0
ZNF207 18 No 0 0
F13A1 19 No 63 81
DYNLL1 20 No 12 0
The numbers listed in the last two columns indicate, respectively, the number
of functional annotations and diseases linked to the corresponding genes in the
Entrez Gene database and HuGE Navigator knowledge base.
doi:10.1371/journal.pone.0013748.t001
Figure 5. Comparisons in terms of biological meaning. The
numbers of DM2 gene sets identified by different methods are
compared.
doi:10.1371/journal.pone.0013748.g005
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100 or 400 genes.
MiNeGS detected 35 DM2-associated functional subsets, with a
p-value,0.1, when used to select 300 genes. The subsets with the
highest significance (p-value,0.01) amongst these 35 subsets are
listed in Table 2. This list covers a number of DM2-assocated
processes or functions, such as fatty acid oxidation, hormone
activity, insulin signaling, and glucose metabolism, among others.
Based on these results, MiNeGS offers a clear advantage over
classical GS in the identification of functional gene sets when used
to select increasing numbers of genes, and performs as well or
better than NeGS when used to select any number of genes.
F. Conclusions
Microarray data analysis for the selection of candidate genes is
often the crucial step in the analysis of the molecular mechanisms
of complex biological phenomena and diseases. Gene network
information has been incorporated into microarray-based GS
studies to reflect the fact that a gene may interact with several
other genes to exert its phenotype.
In this paper, we present a novel network-embedded GS model.
In a network-embedded model, identifying gene functional
partners is the crucial aspect. To effectively cope with this issue,
we address two challenges and make contributions from two
perspectives. First, in order to improve upon the limitations of
microarray data, we now propose a method to combine
microarray expression data with mRNA:microRNA binding
information. This approach attempts to account for microRNA
posttranscriptional effects on mRNA levels in order to better
estimate the ultimate expression of a given gene. Second, we
introduce the concept of diffusion distance to estimate the degree
of interaction of all gene pairs. With this concept, we can include
network connections, and take into account all possible paths
connecting gene pairs. These capabilities are needed to reflect the
complicated mechanism of gene interaction that can occur in even
simple biological systems.
We have evaluated these proposed strategies from both
computational and biological perspectives. Our results show that
an approach that integrates microRNA binding data with
expression data can enhance the identification performance of
functional partners of genes. More importantly, comparison of
MiNeGS and it component methods with classical GS method-
ology clearly shows the advantages of the proposed strategies since,
after applying these strategies, GS performance is enhanced and
selected genes demonstrate higher classification capabilities.
MiNeGS selected more previously-reported disease genes than
the classic GS model when these methods were used to analyze a
DM2 data set. Gene-set-enrichment analysis results also showed
that the MiNeGS gene lists contained many well-known or newly-
confirmed DM2-associated processes and pathways. In summary,
these results suggest that GS results from the MiNeGS method
provide high-quality, and functionally relevant biological infor-
mation, in this case showing promise to identify genes involved in
DM2.
Materials and Methods
A. Data
In order to evaluate our GS models we used a previously
published microarray data [23] which was derived from the
skeletal muscle biopsies of 43 age-matched men with normal
glucose tolerance (NGT, number of samples=17), impaired
glucose tolerance (IGT, N=8), or diabetes type II (DM2,
N=18). We omitted all IGT subject data to compare DM2-
associated changes between NGT and DM2 groups. Similar to
the original study by Mootha et. al. [23], we deleted genes that
demonstrated low expression over the entire dataset. Genes with
expression values ,100 were considered to be unexpressed, and
genes whose average expression were ,100 were excluded from
our analysis. Genes with low variation (standard deviations
,0.2) across samples were also excluded from analysis, since, for
these genes, experimental noise may markedly contribute to
variation.
The microRNA:gene target and gene network data used in our
models downloaded from public databases. We download
experimentally-verified microRNA targets from TarBase (http://
diana.cslab.ece.ntua.gr/tarbase/) and computationally predicted
microRNA target results from PicTar (http://pictar.mdc-berlin.
de/) and TargetScan (http://www.targetscan.org/). Due to the
scarcity of experimentally-verified results, microRNA:target as-
signments are largely derived from computational predictions.
Most existing prediction models, such as TargetScan, miRanda,
PicTar, RNA22, etc, adopt similar principles (the microRNA
binding sites must match to the seeds of microRNAs in a Watson-
Crick pairing way and must be evolutionarily conserved) and differ
only in their technical details [16]. Also in order to control false
positive rate of prediction, we concentrated on the methods that
use stringent seed-matching criteria and consider the evolutionary
conservation of binding sites [34]. Two well-developed tools,
PicTar and Targetscan, were thus considered in our study. A
microRNA is considered to bind an mRNA when this relationship
is supported by experimental evidence, or predicted by either
PicTar or Targetscan. Finally, microRNAs that have ,100 targets
were considered not to be well-studied and were excluded from
this study.
Following other studies [11,12,29], we used protein-protein
interaction databases to build our network. Here we explored
information provided by STRING (search tool for the retrieval of
interacting genes/proteins). STRING is a comprehensive data-
base, collecting the interactions from well-known resources, such
as MINT, HPRD, BIND, DIP, BioGRID, KEGG, NCI-Nature
Pathway Interaction, among others [30]. The interactions
provided in STRING cover a wide spectrum of cell types and
environmental conditions, and a part of them work in our studied
scenario. To exclude irrelevant interactions, we eliminated those
having negative mRNA-based correlations.
Table 2. Gene subsets enriched by highly significant
(corrected p value,0.01) MiNeGS genes.
Functional Gene Subset
1 GO:0006635 fatty acid beta-oxidation process
2 GO:0005179 hormone activity function
3 GO:0046982 protein heterodimerization activity function
4 GO:0008286 insulin receptor signaling pathway
5 GO:0004871 signal transducer activity function
6 GO:0006006 glucose metabolic process
7 KEGG IL4 receptor in B lypthocytes
8 KEGG Type II diabetes mellitus
9 PID insulin pathway
10 PID the ptp1b-mediated signaling pathway
11 PID the txa2-medicated signaling pathway
doi:10.1371/journal.pone.0013748.t002
MiRNA Network Gene Selection
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interactions with others, and the microRNAs having sparse
binding targets, we finally arrived at 1977 genes and 489
microRNAs. Among those genes, 1338 (67%) are (potentially)
bound by microRNAs. Also, we have up to 80,000 interactions.
The distribution of connection degrees of genes follows a power
law – 637 genes (32%) have less-than 10 connections, while only
24 genes (4.3%) have more-than-150 ones.
B. Methods
Our system, as overviewed in Fig. 1, includes three components
(A, B and C), and uses as input microarray expression data,
microRNA binding composition data and a priori known gene
networks. Through integrating the first two types of data, the
correlations between genes are evaluated. Then after overlaying
those gene correlation estimates onto gene networks, by using the
concept of diffusion distance, the nearest functional partners
(NFPs) of each gene are detected. Finally, based on microarray
expression data and NFP identifications, the gene-phenotype
association is estimated for each gene, and the genes having high
associations are naturally marked out as biomarker gene. Our
main contributions lie in the part A and B.
Suppose we have a gene expression dataset D={X, Y}.
X=[x1,…xj,…,xn] records the transcriptional profiles having m
genes for n samples, and xi=[xi1,…xij,…,xin]
T (1ƒiƒm) where xij
is the transcriptional expression of the ith gene in the jth sample.
Y=[y1,…yj,…,yn] where yj indicates the phenotypic responses of
the jth samples. Also the potential binding relationships between m
genes and k microRNAs are collected in a binary matrix
Z=[ziq]m6k, where ziq=1 indicates that the ith gene can be
hybridized and then regulated by the qth microRNA based on
experimental or computational prediction results, otherwise
ziq=0. To construct Z, we combine the results of biological
experiments and well-developed microRNA target predication
tools, as detailed in the last section. Finally, we have a graph
V={V, E} to reflect a prior known gene networks. The vertex set
V is our gene set, covering all studied m genes. The edge matrix
E=[eij]m6m. When the ith gene and the jth are connected together
based on known gene networks, we have eij=1; otherwise eij=0.
B.1 MicroRNA-integrated Gene Correlation. In order to
search NFPs of genes, estimating gene correlation is the first step.
For this purpose, we consider two factors – one is the
transcriptional expressions of genes, which are given in
microarray gene expression data, and the other is the potential
post-transcriptional effects on gene expression, which is critical in
certain cases and which we believe has not received enough
emphasis in current GS studies.
Given two genes (say, the ith and jth genes in our data), their
transcriptional expressions are stored in xi and xj, and their
microRNA binding compositions are described by zi and zj.T o
evaluate the correlation between xi and xj, we use Pearson
correlation coefficient (PCC). As to microRNA-binding composition
binary variables, we explore the concept of Jaccard similarity
coefficient. Jaccard similarity coefficient (J), measuring the percent-
age of nonzero coordinates that are same, is defined in a way of
Jij~
S
(11)
ij
S
(10)
ij zS
(01)
ij zS
(11)
ij
,1 ƒi,jƒm ð1Þ
whereS
(11)
ij isthenumberofrsatisfyingzir=zjr=1.Similarly,S
(10)
ij is
the number of r with zir=1 and zjr=0, while S
(01)
ij is for zir=0 and
zjr=1.A largeJij indicatesthat two genesareregulatedbymuch like
microRNA sets. Jij arrives its maximum 1 when two corresponding
genes are regulated by the same group of microRNAs. Moreover,
we have J=1 between two non-microRNA-binding genes, while
J=0 between a microRNA-binding and a non-microRNA-binding
gene.
Combining the Pearson correlation coefficient PCCij and
Jaccard similarity coefficient Jij together, we finally have the
correlation between the ith and the jth gene as
Cij~PCCijzJij,1 ƒi,jƒm ð2Þ
B.2 Network-embedded Functional Nearest Partners
based on Diffusion Map. It has been reported that the
sensitivity and specificity of GS can be enhanced by inclusion of
gene network data. Our study examines the capability of a gene not
only based on its expression but also on the expression of its working
partners. For each gene, we detect its nearest functional partners
(NFPs). The idea behind our NFP identification is that, in order to
work together, a gene (say, gi) and its NFPs must have highly-correlated
expressions, and at the same time belong to the same pathway.
Given a gene network, two genes are first-order neighbor to each
other when they have a direct connection. Two genes are high-
order neighbors to each other when they are connected through
other genes. Based on the gene network and our gene correlation
estimates (eq. 2), the straightforward way to identify the NFPs of gi is
to sort out the genes having top expressional correlations to gi,
among all the first-order neighbors of gi. Focusing on first-order
neighbors is not enough when it is known that, through the
propagation of biological signals, a gene may interplay with its high-
order neighbors. In order to include high-order neighbors for
functional neighbor examination, one may consider the concept of
shortest path in the graphic theory and measure the distance of two
genes as the length of the shortest path between them. The problem
underlying this idea is that, in complicate gene networks, two genes
may be connected through different paths, and two genes may
closely collaborate when they are modestly connected through
many paths in a gene network. As such, the shortest path is not
comprehensive enough to capture the information of all the paths
connecting two genes. To this end, we resort to diffusion distance
and diffusion maps to detect NFPs. Diffusion distance is defined to
measure the distance between graph nodes with considerations of
the information of high-order neighborhood, whilst diffusion maps
allows us to evaluate diffusion distance in an effective way.
Diffusion distance was first proposed by Coinfman et al. [22]
and has been used for dimensionality reduction and graph-based
data clustering [31,32]. The final goal of diffusion-distance-based
methodologies is to reduce the complexity of a given dataset while
retaining original geometry as much as possible. To achieve this
goal, a finite graph is firstly constructed to accurately reflect
geometric relations among given data points. In our example, such
graph is built through weighting the edges of the gene network V
with gene correlation estimates. In this correlation-weighted
graph, the vertices are all studied genes, while the edge matrix,
below denoted as W~½wij 1ƒi,jƒm, is determined by
wij~eij|Cij forCijw0, and wij~0fo rCijv0, 1ƒi,jƒm,
where eij is an edge of V. eij is 1 when the ith and jth genes are
connected in the network V; otherwise eij=0.W is symmetric since
W~WT, i.e., wij~wji. Also, W is pointwise positive because of
wij§0 (1ƒi,jƒm). Further, a diagonal matrix D is built so that its
diagonal element djj (1ƒjƒm) is the sum of similarities of the jth
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Pm
i~1 wij. Normalizing W with D,
we arrive at Q~D{1W. Clearly, we have
Pm
i~1 qij~ Pm
i~1 wij
 
djj~1, i.e., the sum of elements in a column of Q is 1.
With this observation, Q can be seen as a Markov random
transition matrix, and qij is thus interpreted as the probability of
transition from the ith to the jth gene in one time step. Instatistical
nomenclature, qij~Prfx(t0zDtg~gjDx(t0g~gig, where t0 and
Dt are the initial time and a time step, respectively. By Q, the
first-order neighbor closeness between genes is explicitly reflected.
Furthermore, Q
2 is a Markov transition matrix since
PN
i~1
PN
k~1 (qikqkj)~
PN
k~1 qik
PN
k~1 qkj
  
~1. An element in
Q
2 (below denoted as Q2 for the sake of convenience) can be
regarded the probability of one gene to another in two random
walk steps. For example, we have q2,ij~Prfx(t0z2Dtg~
gjDx(t0g~gig. Along this reasoning direction, an element in Ql
gives us the probability of signal propagating from one gene onto
another after l random walking steps. The above analysis shows
that, by taking powers of Q, the signals are diffused forward in the
gene networks, and the elements in Ql reflect gene similarity after
considering high-order neighborhood. Below, for simplification, we
set t0=0, and denote p(t,gjDgi) and Qt respectively as
Prfx(t)~gjDx(0)~gig andthe transition matrix atthe tth time unit.
Based on the matrix Qt, the next step is to measure the distance
between graph nodes. Given a graph, two nodes will be close if
they are connected through several paths. The more paths two
nodes are connected by, the closer they may be. To reflect this
fact, the diffusion distance at the time t is defined as the weighted
Euclidean distance, i.e.,
D2
t(gi,gj)~ p(t,gijgk){p(t,gjjgk)
       2
1=w0
~
XN
k~1
(p(t,gijgk){p(t,gjjgk))
2
w0(gk)
,
ð3Þ
where w0(gk) is the normalized degree of gk, i.e., w0(gk)~
Dkk
PN
j~1 Djj
. With w0(gk)(1ƒkƒN), the diffusion distance (eq. 3)
takes into account the empirical local density of graph nodes (i.e.,
genes in our example), giving the emphasis on the low-density
nodes and avoiding the dominant of the high-density ones.
Following the studies in the spectral clustering, the eigenvectors
of the transit matrix Qt are used to map the original space to a new
space where the clusters of the points are presented in a clearer
way than in the original space. Our m-dimensional Markov
transition matrix Q has m eigenvalues1~l0§l1§:::§lm, with
the corresponding eigenvectors { j,1 ƒjƒm} that satisfy
M j~l j. Using the top rescaled L eigenvectors as a new set of
coordinates, the original genes (represented by the correlation-
weighted graph) are mapped to an L-dimensional Euclidean space by
Yt(g)~(l
t
1 1(g),l
t
2 2(g),:::,l
t
L L(g)):
Such a process is called diffusion mapping. As proved by Nadler et al.
[33], the diffusion distance (eq. 3) can be accurately approximated by
the Euclidean distance in the new space, i.e.,
D2
t(gi,gj)~ Yt(gi){Yt(gi) kk
2, ð4Þ
The diffusion distance (eqs. 3–4) negatively reflects the
collaboration relationship between genes. Based on this index,
for a given gene, we detect out its k nearest neighbors. After
placing gene correlation estimation onto gene networks, we
construct a weighted graph whose nodes cover all genes, and
whose edges reflect the first-order collaboration probability
between genes. Upon this graph, the Markov matrix Qt makes
us simulate the situation of biological signal propagation, reflecting
interplay between genes, either directly or indirectly connected.
With Qt, the diffusion distance (eqs. 3–4) enables us to follow the
biological nature that genes may collaborate through the multi-
paths to estimate their collaboration closeness.
B.2 Network-embedded Gene-phenotype association. A
gene always varies in a similar way with their functional partners.
Based on this idea, Chuang et al. [29] averaged the normalized
expression levels of the genes within a sub-network, and used this
average to check whether that sub-network was associated to breast
cancer metastasis or not. A gene sub-network here is a set of genes that
are functional partners to each other. Rapaport et al. [11] detected
working partners for each gene from its first-order-neighbors. Then,
after assuming that genes have the similar expressions with their
working partners, they filtered out high-frequency noise in expression
data to enhance the performance of GS and classification.
Based upon microarray data, we first evaluate the correlation
between genes and the phenotype response. Many indexes, such as
student t test, Kruskal-Wallis test and mutual information (MI),
can be used for this purpose. In this study, MI is employed in that
MI is a flexible nonparametric tool and can measure the
relationship of variables with arbitrary distributions. Given a gene
(say gi, its expression variable is xi), the MI of that gene to the
discrete phenotype response variable y is defined as
MI(gi,y)~
X
y
ð
xi
p(xi,y)log
p(xi,y)
p(xi)p(y)
dxi,1 ƒiƒm: ð5Þ
We estimate MI (eq. 5) in a popularly-used way where the space of
xi is equally divided into 10 bins at first and histograms for p(x,y)
and p(x) are then built.
Based on MI estimates and NFP identifications, we determine
the gene-phenotype association (GPA) as the average of MIs of
genes and their NFPs. That is, for the gene gi, we have
GPA(gi)~
1
DNFP(gi)D
X
gk[NFP(gi) MI(gk,y), 1ƒiƒm
where |a| denotes the number of the items in a. Based on GPA
estimates, the genes are finally ranked in terms of association.
C. Classification Scheme
GS models are evaluated in terms of classification performance.
A GS model is firstly required to select J genes. Then by using
those J genes, two typical classification models are built. Good
performance of the built classifiers naturally implies a good gene
subset, or equivalently, a promising GS model.
To avoid ‘‘information leakage’’, we adopted a cross validation
scheme. The 35 samples of our dataset were partitioned into 6
groups, each containing 6 samples (3 DM2 and 3 NGT) except for
the last group that has 5 samples (2 NGT and 3 DM2). For each
run, five data groups are used for GS and classifier training, while
the remained group is used for a classification test. This process is
repeated 6 times, with each of the 6 groups used in turn. After that
all the testing results are summarized together. In order to
minimize random variations introduced by data-partitioning, we
independently ran the cross-validation process 20 times, and
averaged the results of these trials.
MiRNA Network Gene Selection
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networks and support vector machine, which are available at
NetLab (http://www.ncrg.aston.ac.uk/netlab/index.php) and the
University of Southhampton ISIS website (http://www.isis.ecs.
soton.ac.uk/resources/svminfo/), respectively. The number of
hidden neurons of neural networks are set as J
1/2 , where a
is denoted as the integral part of the value a and J is the number of
the genes we use for classification. For support vector machines,
we use radial base functions as their kernels. Other parameters and
initial values for our classifiers are set by the model defaults.
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